About Robert Jackson
Form D filings for Perceive Biotherapeutics in 2023 list Robert Jackson as director.
Robert Jackson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Jackson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Jackson works with at each company, as listed on that company's latest Form D.
Perceive Biotherapeutics, Inc. · Form D, Jan 13, 2023
WD
Watson Debi
Director
AR
Anne Rubin
Executive officer and director
KM
Kirsten Macfarlane
CEO and director
CW
Cameron Wheeler
Director
RO
Randall Olson
Director